TCR1020-CD8 T cells

· University of Pennsylvania

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TCR1020-CD8 T cells, covering 2025-06-25 to 2025-06-25. Get the full timeline:

Most recent: Clinical Trial Update: TCR1020-CD8 T Cells in KRAS-mutated Cancers [Phase 1]